Immunoblot analysis revealed visual evidence of a relative increase in cleaved PARP (cPARP) levels in p53-functional ALL cells following 24 h of treatment with RG7388 and BBI608, although this change did not reach statistical significance. The gene discussed is PARP1; the disease is acute lymphoblastic leukemia.